chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lip swelling, Pain, Pyrexia
Clinical narrative: swollen lower lip; body ache; Fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swollen lower lip), PAIN (body ache), PYREXIA (Fever) and CHILLS (chills) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 26-Mar-2021, the patient experienced PAIN (body ache), PYREXIA (Fever) and CHILLS (chills). On 27-Mar-2021, the patient experienced LIP SWELLING (swollen lower lip). On 26-Mar-2021, PAIN (body ache), PYREXIA (Fever) and CHILLS (chills) had resolved. At the time of the report, LIP SWELLING (swollen lower lip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-061102, MOD-2021-061392, MOD-2021-061287 (Patient Link).   Reporter did not allow further contact
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Overweight, Rhinorrhoea, SARS-CoV-2 test positive, Vaccination complication
Clinical narrative: I feel overweight; I had very mild symptoms; I only had a runny nose and blowing my nose a little more then normal.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I had very mild symptoms), RHINORRHOEA (I only had a runny nose and blowing my nose a little more then normal.) and OVERWEIGHT (I feel overweight) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016MZ0M) for COVID-19 vaccination.     The patient's past medical history included COVID-19 PCR test positive.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION COMPLICATION (I had very mild symptoms) and RHINORRHOEA (I only had a runny nose and blowing my nose a little more then normal.). On an unknown date, the patient experienced OVERWEIGHT (I feel overweight). At the time of the report, VACCINATION COMPLICATION (I had very mild symptoms), RHINORRHOEA (I only had a runny nose and blowing my nose a little more then normal.) and OVERWEIGHT (I feel overweight) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: Local injection site pain; Severe knee joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Local injection site pain) and ARTHRALGIA (Severe knee joint pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B214) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, PRAVASTATIN and CEPHALEXIN [CEFALEXIN] for an unknown indication.    On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE PAIN (Local injection site pain) and ARTHRALGIA (Severe knee joint pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1200 milligram. In March 2021, VACCINATION SITE PAIN (Local injection site pain) had resolved. At the time of the report, ARTHRALGIA (Severe knee joint pain) outcome was unknown. Not Provided          Reporter did not allow further contact
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Somnolence
Clinical narrative: Sore arm; Felt sleepy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and SOMNOLENCE (Felt sleepy) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and SOMNOLENCE (Felt sleepy). At the time of the report, PAIN IN EXTREMITY (Sore arm) and SOMNOLENCE (Felt sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: SORE ARM; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (SORE ARM) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PRAVASTATIN and METOPROLOL SUCCINATE (METOPROLOL [METOPROLOL SUCCINATE]) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced MYALGIA (SORE ARM). At the time of the report, MYALGIA (SORE ARM) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details not provided Consent for safety to follow up was received. Patient states she went shopping and had her N-95mask.   This case was linked to MOD-2021-060440 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2021-060440:First dose case
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itchiness on the face, the eyebrows, their eyes, it is all over their face, around their lips and mouth, from the forehead, down to the chin; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness on the face, the eyebrows, their eyes, it is all over their face, around their lips and mouth, from the forehead, down to the chin) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchiness on the face, the eyebrows, their eyes, it is all over their face, around their lips and mouth, from the forehead, down to the chin). At the time of the report, PRURITUS (itchiness on the face, the eyebrows, their eyes, it is all over their face, around their lips and mouth, from the forehead, down to the chin) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported.  Treatment information not provided.   This case was linked to MOD-2021-060434 (E2B Linked Report).; Sender's Comments:  MOD-2021-060434:Valid case.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.            Reporter did not allow further contact
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm at injection site on left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm at injection site on left arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm at injection site on left arm). At the time of the report, VACCINATION SITE PAIN (Sore arm at injection site on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not provided. The treatment information was not provided.  The patient enquired about the immunity time period of the vaccine and also about any tests she can take to test the immunity.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Injection site pain, Paraesthesia, Vaccination site mass
Clinical narrative: The area every now and then feel tingly feeling; lump under her arm pit; Little bit discomfort for couple day afterwards; Arm sore at the injection site from the shot; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (The area every now and then feel tingly feeling), VACCINATION SITE MASS (lump under her arm pit), DISCOMFORT (Little bit discomfort for couple day afterwards) and INJECTION SITE PAIN (Arm sore at the injection site from the shot) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced PARAESTHESIA (The area every now and then feel tingly feeling), VACCINATION SITE MASS (lump under her arm pit), DISCOMFORT (Little bit discomfort for couple day afterwards) and INJECTION SITE PAIN (Arm sore at the injection site from the shot). At the time of the report, PARAESTHESIA (The area every now and then feel tingly feeling), VACCINATION SITE MASS (lump under her arm pit), DISCOMFORT (Little bit discomfort for couple day afterwards) and INJECTION SITE PAIN (Arm sore at the injection site from the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site pain
Clinical narrative: Big blue spot on left arm; Arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Big blue spot on left arm) and VACCINATION SITE PAIN (Arm hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PAIN (Arm hurt). On 23-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH MACULAR (Big blue spot on left arm). At the time of the report, RASH MACULAR (Big blue spot on left arm) and VACCINATION SITE PAIN (Arm hurt) outcome was unknown. Not Provided          No relevant concomitant medication was reported.  Treatment information was not provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pyrexia
Clinical narrative: Fever; Migraine; This spontaneous case was reported by a nurse and describes the occurrence of MIGRAINE (Migraine) and PYREXIA (Fever) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced MIGRAINE (Migraine). On 28-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MIGRAINE (Migraine) and PYREXIA (Fever) was resolving. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MODERNATX, INC.-MOD-2021-030312 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-030312:Cross Linked case
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Malaise, Pyrexia
Clinical narrative: felt unwell; dizziness; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt unwell), DIZZINESS (dizziness), PYREXIA (fever) and CHILLS (chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced MALAISE (felt unwell), DIZZINESS (dizziness), PYREXIA (fever) and CHILLS (chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Body temperature, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Body temperature, at an unspecified dose and frequency. At the time of the report, MALAISE (felt unwell), DIZZINESS (dizziness), PYREXIA (fever) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, Pyrexia: 102 degree Celsius (High) 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was provided as ibuprofen and paracetamol.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: No new information
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: Swollen; Sore; Itchiness; Redness on the left arm extending to the elbow; Low grade temperature; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (Sore), PRURITUS (Itchiness), ERYTHEMA (Redness on the left arm extending to the elbow) and PYREXIA (Low grade temperature) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD. Concomitant products included FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY), MONTELUKAST SODIUM (SINGULAIR), HYDROCHLOROTHIAZIDE, METOPROLOL, CLOPIDOGREL BISULFATE (PLAVIX), ACETYLSALICYLIC ACID (ASPIRIN 81), PREDNISONE, ONDANSETRON (ZOFRAN [ONDANSETRON]), HYDROCODONE and COLECALCIFEROL, MENADIONE (VITAMIN K+D) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (Sore), PRURITUS (Itchiness), ERYTHEMA (Redness on the left arm extending to the elbow) and PYREXIA (Low grade temperature). At the time of the report, PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (Sore), PRURITUS (Itchiness), ERYTHEMA (Redness on the left arm extending to the elbow) and PYREXIA (Low grade temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also include CARDIO-B. The patient has 4 stents in the lung and 1 in the heart. Treatment details include Benadryl and Aleve.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Extrasystoles, Heart rate increased, Palpitations, Throat irritation
Clinical narrative: Heart palpitations; Felt a rush under her throat; Heart was skipping beats; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitations), THROAT IRRITATION (Felt a rush under her throat) and EXTRASYSTOLES (Heart was skipping beats) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018821A) for COVID-19 vaccination.     Concurrent medical conditions included Drug side effect (Patient stated Spiriva inhaler and anything that has acetaminophen and Sudafed caused heart palpitations for her.). Concomitant products included FLUTICASONE PROPIONATE (FLOVENT), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), FAMOTIDINE, MONTELUKAST SODIUM (SINGULAIR), POLYCARBOPHIL CALCIUM (FIBERCON), DOCUSATE SODIUM (COLACE), VITAMINS NOS, SERTRALINE HYDROCHLORIDE (ZOLOFT), PANTOPRAZOLE and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PALPITATIONS (Heart palpitations), THROAT IRRITATION (Felt a rush under her throat) and EXTRASYSTOLES (Heart was skipping beats). At the time of the report, PALPITATIONS (Heart palpitations), THROAT IRRITATION (Felt a rush under her throat) and EXTRASYSTOLES (Heart was skipping beats) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Heart rate increased: increased High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Vaccination site warmth
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of erythema (red), vaccination site warmth (warm), peripheral swelling (swollen) and pruritus (itchy) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 046A21A) for COVID-19 immunization. Concomitant products included rosuvastatin and melatonin. On Mar 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 26, 2021, patient experienced erythema (red), vaccination site warmth (warm), peripheral swelling (swollen) and pruritus (itchy). At the time of the report, erythema (red), vaccination site warmth (warm), peripheral swelling (swollen) and pruritus (itchy) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Movement disorder, Pain, Vaccination site pain
Clinical narrative: It hurt a lot(in reference to receiving the shot); Couldn't move it (arm)/10% range of motion; really sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (It hurt a lot(in reference to receiving the shot)), MOVEMENT DISORDER (Couldn't move it (arm)/10% range of motion) and VACCINATION SITE PAIN (really sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN (It hurt a lot(in reference to receiving the shot)), MOVEMENT DISORDER (Couldn't move it (arm)/10% range of motion) and VACCINATION SITE PAIN (really sore). At the time of the report, PAIN (It hurt a lot(in reference to receiving the shot)), MOVEMENT DISORDER (Couldn't move it (arm)/10% range of motion) and VACCINATION SITE PAIN (really sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Procedural complication, Product dose omission issue
Clinical narrative: Patient had surgery after receiving 1st dose; Patient hasn't received 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PROCEDURAL COMPLICATION (Patient had surgery after receiving 1st dose) and PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced PROCEDURAL COMPLICATION (Patient had surgery after receiving 1st dose) and PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet). At the time of the report, PROCEDURAL COMPLICATION (Patient had surgery after receiving 1st dose) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet) had resolved. Surgery details were not provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: No new information.
Sex: F
Vaccine: COVID19
Symptoms: Herpes virus infection, Pain, Pain in extremity, Rash, Vaccination site pain
Clinical narrative: pressure on the arm (left); Herpes ampoules on back; Rash on right arm; pain on left arm; started to feel pain on the right arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain on left arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported ). Concomitant products included INSULIN, METFORMIN, ATORVASTATIN and PIOGLITAZONE for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain on left arm). At the time of the report, VACCINATION SITE PAIN (pain on left arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Head discomfort, Headache
Clinical narrative: Congestion in the head still; Felt like she had a cold; Feeling more tired than usual; Headache; Contracted covid after 1st dose; Started to get sick; coughing; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), HEAD DISCOMFORT (Congestion in the head still) and NASOPHARYNGITIS (Felt like she had a cold) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Defibrillator/pacemaker insertion.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), NASOPHARYNGITIS (Felt like she had a cold), FATIGUE (Feeling more tired than usual) and HEADACHE (Headache). On an unknown date, the patient experienced HEAD DISCOMFORT (Congestion in the head still). At the time of the report, COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), HEAD DISCOMFORT (Congestion in the head still), NASOPHARYNGITIS (Felt like she had a cold), FATIGUE (Feeling more tired than usual) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included lots of unspecified medications.  No treatment medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nasopharyngitis
Clinical narrative: Congestion in the head still; Felt like she had a cold; Feeling more tired than usual; Headache; Contracted covid after 1st dose; Started to get sick; coughing; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), HEAD DISCOMFORT (Congestion in the head still) and NASOPHARYNGITIS (Felt like she had a cold) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Defibrillator/pacemaker insertion.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), NASOPHARYNGITIS (Felt like she had a cold), FATIGUE (Feeling more tired than usual) and HEADACHE (Headache). On an unknown date, the patient experienced HEAD DISCOMFORT (Congestion in the head still). At the time of the report, COVID-19 (Contracted covid after 1st dose), ILLNESS (Started to get sick), COUGH (coughing), HEAD DISCOMFORT (Congestion in the head still), NASOPHARYNGITIS (Felt like she had a cold), FATIGUE (Feeling more tired than usual) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included lots of unspecified medications.  No treatment medications were reported.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: less than half the dose was administered; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (less than half the dose was administered) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced ACCIDENTAL UNDERDOSE (less than half the dose was administered). At the time of the report, ACCIDENTAL UNDERDOSE (less than half the dose was administered) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment medication was unknown.  This report refers to a case of accidental underdose for mRNA-1273 with no associated AEs.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of accidental underdose for mRNA-1273 with no associated AEs.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough
Clinical narrative: Cough and mucus in throat; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (Cough and mucus in throat) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PRODUCTIVE COUGH (Cough and mucus in throat). At the time of the report, PRODUCTIVE COUGH (Cough and mucus in throat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pain in extremity
Clinical narrative: tested positive for Covid-19; soreness in left arm at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in left arm at the site of the injection) and COVID-19 (tested positive for Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ORAL CONTRACEPTIVE NOS for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in left arm at the site of the injection). On 17-Mar-2021, the patient experienced COVID-19 (tested positive for Covid-19). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness in left arm at the site of the injection) had resolved and COVID-19 (tested positive for Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Oropharyngeal discomfort, Urticaria
Clinical narrative: allergic reaction of hives all over the body; throat started to close; arm pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (allergic reaction of hives all over the body), OROPHARYNGEAL DISCOMFORT (throat started to close) and INJECTION SITE PAIN (arm pain at injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Seafood allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced URTICARIA (allergic reaction of hives all over the body), OROPHARYNGEAL DISCOMFORT (throat started to close) and INJECTION SITE PAIN (arm pain at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, URTICARIA (allergic reaction of hives all over the body), OROPHARYNGEAL DISCOMFORT (throat started to close) and INJECTION SITE PAIN (arm pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Fatigue; Headache; Muscle pain; Some nausea; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain) and NAUSEA (Some nausea) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain) and NAUSEA (Some nausea). On 17-Mar-2021, FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain) and NAUSEA (Some nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up received on 09 Jul 2021 with route of administration and patient's address was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Eye movement disorder
Clinical narrative: Eye was quivering and trembling for a short while; This spontaneous case was reported by a consumer and describes the occurrence of EYE MOVEMENT DISORDER (Eye was quivering and trembling for a short while) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Nerve damage (left nerve damage). Concomitant products included VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]) and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced EYE MOVEMENT DISORDER (Eye was quivering and trembling for a short while). At the time of the report, EYE MOVEMENT DISORDER (Eye was quivering and trembling for a short while) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also include hair, skin, nails vitamins Treatment details not provided.     Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: TCR was received the details was for second dose outcome has been resolved and requested no further follow up On 27-May-2021: Event outcome updated.; Sender's Comments:  MODERNATX, INC.-MOD-2021-060506:2nd dose
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chapped lips, Lip pruritus, Lip swelling, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: looked like a chapped lip; lips itching; Whole top lip was swelled up; red spot on arm at injection site; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHAPPED LIPS (looked like a chapped lip), LIP PRURITUS (lips itching), LIP SWELLING (Whole top lip was swelled up), VACCINATION SITE ERYTHEMA (red spot on arm at injection site) and VACCINATION SITE PRURITUS (itching at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHAPPED LIPS (looked like a chapped lip), LIP PRURITUS (lips itching), LIP SWELLING (Whole top lip was swelled up), VACCINATION SITE ERYTHEMA (red spot on arm at injection site) and VACCINATION SITE PRURITUS (itching at the injection site). The patient was treated with NYSTATIN at an unspecified dose and frequency; TRIAMCINOLONE at an unspecified dose and frequency and ACETONIDE DE FLUCLOROLONE (topical) at an unspecified dose and frequency. At the time of the report, CHAPPED LIPS (looked like a chapped lip), LIP PRURITUS (lips itching), LIP SWELLING (Whole top lip was swelled up), VACCINATION SITE ERYTHEMA (red spot on arm at injection site) and VACCINATION SITE PRURITUS (itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Mass
Clinical narrative: Tiredness; Lump on arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) and MASS (Lump on arm) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 25A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tiredness) and MASS (Lump on arm). At the time of the report, FATIGUE (Tiredness) and MASS (Lump on arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication include Blood thinner.  No treatment medications was reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow-up document was add on 02-JUL-2021. Event outcome was changed to Recovered and Resolved.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Reports arm hurt at the injection site that day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Reports arm hurt at the injection site that day) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (Reports arm hurt at the injection site that day). On 06-Mar-2021, VACCINATION SITE PAIN (Reports arm hurt at the injection site that day) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 037I20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced HEADACHE (headache). On 27-Mar-2021, HEADACHE (headache) had resolved. Not Provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Head discomfort, Headache
Clinical narrative: Light headache; Pressure on the back of the head; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HEADACHE (Light headache) and HEAD DISCOMFORT (Pressure on the back of the head) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Dizziness). On 29-Mar-2021, the patient experienced HEADACHE (Light headache) and HEAD DISCOMFORT (Pressure on the back of the head). On 27-Mar-2021, DIZZINESS (Dizziness) had resolved. At the time of the report, HEADACHE (Light headache) and HEAD DISCOMFORT (Pressure on the back of the head) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Myalgia, Oxygen saturation decreased, Pyrexia
Clinical narrative: O2 level went down to 88; Feels like she is out of body; Achy feeling; Fever of 103F; Lightheadedness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness), OXYGEN SATURATION DECREASED (O2 level went down to 88), FEELING ABNORMAL (Feels like she is out of body), MYALGIA (Achy feeling) and PYREXIA (Fever of 103F) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced DIZZINESS (Lightheadedness), MYALGIA (Achy feeling) and PYREXIA (Fever of 103F). On 29-Mar-2021, the patient experienced FEELING ABNORMAL (Feels like she is out of body). On an unknown date, the patient experienced OXYGEN SATURATION DECREASED (O2 level went down to 88). On 26-Mar-2021, DIZZINESS (Lightheadedness) had resolved. On 28-Mar-2021, PYREXIA (Fever of 103F) had resolved. At the time of the report, OXYGEN SATURATION DECREASED (O2 level went down to 88), FEELING ABNORMAL (Feels like she is out of body) and MYALGIA (Achy feeling) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment for the event included acetaminophen and ibuprofen.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: warm on arm around injection site; itchy on arm around injection site; red on arm around injection site; rash on arm around injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm on arm around injection site), VACCINATION SITE PRURITUS (itchy on arm around injection site), VACCINATION SITE ERYTHEMA (red on arm around injection site) and VACCINATION SITE RASH (rash on arm around injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (warm on arm around injection site), VACCINATION SITE PRURITUS (itchy on arm around injection site), VACCINATION SITE ERYTHEMA (red on arm around injection site) and VACCINATION SITE RASH (rash on arm around injection site). At the time of the report, VACCINATION SITE WARMTH (warm on arm around injection site), VACCINATION SITE PRURITUS (itchy on arm around injection site), VACCINATION SITE ERYTHEMA (red on arm around injection site) and VACCINATION SITE RASH (rash on arm around injection site) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was reported.    This case was linked to MODERNATX, INC.-MOD-2021-060987 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-060987:friend case
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Feeling hot, Injection site pain
Clinical narrative: chills with goosebumps; extremely hot with chest; extremely hot with thigh; injection site was little tender; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills with goosebumps), CHEST PAIN (extremely hot with chest), FEELING HOT (extremely hot with thigh) and INJECTION SITE PAIN (injection site was little tender) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced CHEST PAIN (extremely hot with chest), FEELING HOT (extremely hot with thigh) and INJECTION SITE PAIN (injection site was little tender). On an unknown date, the patient experienced CHILLS (chills with goosebumps). At the time of the report, CHILLS (chills with goosebumps), CHEST PAIN (extremely hot with chest), FEELING HOT (extremely hot with thigh) and INJECTION SITE PAIN (injection site was little tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medication include very low dose of cholesterol medication.   This case was linked to MOD-2021-060498 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Peripheral swelling, Rash
Clinical narrative: Muscle pain; Slightly pinkish rash on muscle part of arm; Very little swollen; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain), RASH (Slightly pinkish rash on muscle part of arm) and PERIPHERAL SWELLING (Very little swollen) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced MYALGIA (Muscle pain), RASH (Slightly pinkish rash on muscle part of arm) and PERIPHERAL SWELLING (Very little swollen). At the time of the report, MYALGIA (Muscle pain), RASH (Slightly pinkish rash on muscle part of arm) and PERIPHERAL SWELLING (Very little swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included Cholesterol meds for an unknown indication. No Treatment products included